Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04321616Phase 2/3Unknown
The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients
Acute Respiratory Distress Syndrome ARDSCOVID 19SARS-CoV Infection
PrincipalinvestigatorStart date: 2020-03-28
NCT01439841Not ApplicableCompleted
The Effect of Probiotics in HIV-1 Infection
HIV-1 Infection
Principalinvestigator

Research Network

Collaboration Network

8 collaborators·22 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Paul Aukrust, MD, Professor

Oslo University Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, AcuteCOVID-19SARS-CoV Infection

Worked with same sponsors:

Oslo University Hospital
Collaborated on 1 trial
Similarity Score34%

Anne Margarita Dyrhol Riise, MD, Professor

Oslo University Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, AcuteCOVID-19SARS-CoV Infection

Worked with same sponsors:

Oslo University Hospital
Collaborated on 1 trial
Similarity Score34%

Trine Kåsine, MD

Oslo University Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, AcuteCOVID-19SARS-CoV Infection

Worked with same sponsors:

Oslo University Hospital
Collaborated on 1 trial
Similarity Score34%

Inge Christoffer Olsen, PhD

NorCRIN

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, AcuteCOVID-19SARS-CoV Infection

Worked with same sponsors:

Oslo University Hospital
Collaborated on 1 trial
Similarity Score34%

Katerina Nezvalova-Henriksen, Pharm D, PhD

Oslo Hospital Pharmacies

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, AcuteCOVID-19SARS-CoV Infection

Worked with same sponsors:

Oslo University Hospital
Collaborated on 1 trial
Similarity Score34%

Andreas Barratt-Due, MD, PhD

Oslo University Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, AcuteCOVID-19SARS-CoV Infection

Worked with same sponsors:

Oslo University Hospital
Collaborated on 1 trial
Similarity Score34%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19SARS-CoV Infection
Similarity Score15%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, AcuteCOVID-19
Similarity Score15%

Mike Royal, MD

Sorrento Therapeutics, Inc.

Related
19 trials

Shared therapeutic areas:

COVID-19Respiratory Distress Syndrome, Acute
Similarity Score15%

Geir Gokstad, MD, PhD

Oslo University Hospital

Related
1 trials

Shared therapeutic areas:

HIV-1 Infection

Worked with same sponsors:

Karolinska University HospitalOslo University Hospital+1 more
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04321616Phase 2/3PrincipalInvestigator

The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients

Acute Respiratory Distress Syndrome ARDSCOVID 19SARS-CoV Infection
Unknown
NCT01439841Not ApplicablePrincipalInvestigator

The Effect of Probiotics in HIV-1 Infection

HIV-1 Infection
Completed

All 2 trials loaded